These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 3095299

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Antimicrobial resistance and prevalence of extended spectrum beta-lactamase among clinical isolates of gram-negative bacteria in Riyadh.
    El-Karsh T, Tawfik AF, Al-Shammary F, Al-Salah S, Kambal AM, Shibl AM.
    J Chemother; 1995 Dec; 7(6):509-14. PubMed ID: 8667034
    [Abstract] [Full Text] [Related]

  • 23. [Preclinical evaluation of meropenem, a new parenteral carbapenem].
    Edwards JR.
    New Microbiol; 1995 Oct; 18 Suppl():19S-31S. PubMed ID: 8574929
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Susceptibility to new beta-lactams of enterobacterial extended-spectrum beta-lactamase (ESBL) producers and penicillin-resistant Streptococcus pneumoniae in Mexico.
    Silva J, Aguilar C, Estrada MA, Echániz G, Carnalla N, Soto A, López-Antuñano FJ.
    J Chemother; 1998 Apr; 10(2):102-7. PubMed ID: 9603634
    [Abstract] [Full Text] [Related]

  • 27. [Comparative antibacterial activity of a new monobactam, carumonam (RO 17-2301, AMA 1080) on hospital bacteria resistant to beta lactams].
    Le Noc P, Croize J, Le Noc D.
    Pathol Biol (Paris); 1987 May; 35(5):451-6. PubMed ID: 3302846
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12).
    Sader HS, Farrell DJ, Castanheira M, Flamm RK, Jones RN.
    J Antimicrob Chemother; 2014 Oct; 69(10):2713-22. PubMed ID: 24917579
    [Abstract] [Full Text] [Related]

  • 30. [in vitro activity of carbapenems against Enterobacteriaceae and Pseudomonas aeruginosa hyperproducers of group 1 chromosomal beta-lactamases].
    Martínez-Beltrán J, Calderón C, Sierra MP, Alvarez M, Cantón R.
    Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():20-6. PubMed ID: 9410065
    [Abstract] [Full Text] [Related]

  • 31. Use of cefotaxime or ceftazidime susceptibility tests for predicting susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa.
    Heym B, Lacroix O, Péan Y, Gertner J, Nicolas MH, Jarlier V.
    J Antimicrob Chemother; 1994 Apr; 33(4):729-35. PubMed ID: 8056691
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Temocillin. In vitro activity compared with other antibiotics.
    Martinez-Beltran J, Loza E, Gomez-Alferez A, Romero-Vivas J, Bouza E.
    Drugs; 1985 Apr; 29 Suppl 5():91-7. PubMed ID: 3875477
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. In vitro activity of ceftazidime, ceftaroline and aztreonam alone and in combination with avibactam against European Gram-negative and Gram-positive clinical isolates.
    Testa R, Cantón R, Giani T, Morosini MI, Nichols WW, Seifert H, Stefanik D, Rossolini GM, Nordmann P.
    Int J Antimicrob Agents; 2015 Jun; 45(6):641-6. PubMed ID: 25748553
    [Abstract] [Full Text] [Related]

  • 37. In-vitro activity of pefloxacin against micro-organisms multiply resistant to beta-lactam antibiotics and aminoglycosides.
    Verbist L.
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():11-7. PubMed ID: 3086278
    [Abstract] [Full Text] [Related]

  • 38. The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactam.
    Jones RN, Barry AL, Thornsberry C, Fuchs PC, Packer RR.
    Am J Clin Pathol; 1986 Nov; 86(5):608-18. PubMed ID: 3096130
    [Abstract] [Full Text] [Related]

  • 39. Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group.
    Spencer RC.
    Scand J Infect Dis Suppl; 1993 Nov; 91():25-32. PubMed ID: 8290900
    [Abstract] [Full Text] [Related]

  • 40. Activity of ceftazidime against Gram-negative bacilli from paediatric patients.
    Nelson JD, Shelton S.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():179-81. PubMed ID: 19802983
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.